Santa Ana, CA. June 14, 2010: MP Biomedicals LLC announced today that it has signed a definitive agreement to acquire the assets of ICPbio International LTD., an Auckland; New Zealand based protein biologics manufacturing company subject to normal closing adjustments. This acquisition places MP Biomedicals in a strong position to pursue sales and distribution of serum protein products used in research and manufacturing in the Biopharmaceutical, In vitro diagnostic and Biotech sectors. Milan Panic, Chairman and CEO of MP Biomedicals said, \"We feel that this world class protein separation platform provides the manufacturing organization resources needed for MP Biomedicals to more fully serve customer demands for quality, low-risk serum protein materials collected and produced in the pristine environment of New Zealand.\"

ICPbio Ltd., utilizes a state of the art chromatographic extraction which ensures high purity, intact proteins, and processes without the denaturing effect of conventional precipitation methods of manufacture furthermore; the technology and quality systems ensure a high level of process control and product consistency, meeting the stringent demands of the bio-pharmaceutical industry. The product line includes Thrombin, Transferrin, Albumin and IGg. MP will distribute and sell these products worldwide.
 

2010年6月14日，MP Biomedicals LLC 在美国加州圣安娜宣布已正式收购新西兰ICPbio International LTD公司。新西兰ICPbio公司是一家致力于蛋白生物制剂研发和生产的公司。此次收购将会使MPBio公司在生物蛋白制品市场上处于强有力的地位。MPBio公司CEO米兰帕尼奇先生在接受采访时这样说到：MPBio公司需要更充分的满足客户的需求，因此我们需要在新西兰这样纯净的环境中收集和生产高质量，低毒性的血清蛋白，而ICPbio 这样一个世界级的平台恰好提供了这些！

ICPbio 公司利用高水平的层析法分离提取高纯度，完整的蛋白质，而且过程中不会导致蛋白变性。另外，工艺质量系统保证了产品的质量水平及质量统一。公司的产品线包括凝血酶，铁蛋白，白蛋白及抗体。

在接下来的时间里，MPBio公司将为世界范围内的客户提供这些高质量的产品！